Literature DB >> 24966625

Hepatic venous pressure gradient measurement before TIPS for acute variceal bleeding.

Xing-Shun Qi1, Dai-Ming Fan1.   

Abstract

Hepatic venous pressure gradient (HVPG) is an independent predictor of variceal rebleeding in patients with cirrhosis. After pharmacological and/or endoscopic therapy, the use of a transjugular intrahepatic portosystemic shunt (TIPS) may be necessary in HVPG non-responders, but not in responders. Thus, HVPG measurement may be incorporated into the treatment algorithm for acute variceal bleeding, which further identifies the candidates that should undergo early insertion of TIPS or maintain the traditional pharmacological and/or endoscopic therapy. The potential benefits are to reduce the cost and prevent TIPS-related complications.

Entities:  

Keywords:  Acute variceal bleeding; Hepatic venous pressure gradient; Liver cirrhosis; Transjugular intrahepatic portosystemic shunt

Mesh:

Year:  2014        PMID: 24966625      PMCID: PMC4064100          DOI: 10.3748/wjg.v20.i23.7523

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  5 in total

1.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Arun J Sanyal; Norman D Grace; William Carey
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

Review 2.  Management of varices and variceal hemorrhage in cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Jaime Bosch
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

Review 3.  Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage.

Authors:  Romaric Loffroy; Louis Estivalet; Violaine Cherblanc; Sylvain Favelier; Pierre Pottecher; Samia Hamza; Anne Minello; Patrick Hillon; Pierre Thouant; Pierre-Henri Lefevre; Denis Krausé; Jean-Pierre Cercueil
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

4.  Early use of TIPS in patients with cirrhosis and variceal bleeding.

Authors:  Juan Carlos García-Pagán; Karel Caca; Christophe Bureau; Wim Laleman; Beate Appenrodt; Angelo Luca; Juan G Abraldes; Frederik Nevens; Jean Pierre Vinel; Joachim Mössner; Jaime Bosch
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

5.  Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy.

Authors:  Juan G Abraldes; Cándid Villanueva; Rafael Bañares; Carles Aracil; Maria Vega Catalina; Juan Carlos Garci A-Pagán; Jaime Bosch
Journal:  J Hepatol       Date:  2007-11-26       Impact factor: 25.083

  5 in total
  4 in total

Review 1.  Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.

Authors:  Ki Tae Suk; Dong Joon Kim
Journal:  World J Hepatol       Date:  2015-03-27

2.  Hepatic venous pressure gradient-guided laparoscopic splenectomy and pericardial devascularisation versus endoscopic therapy for secondary prophylaxis for variceal rebleeding in portal hypertension (CHESS1803): study protocol of a multicenter randomised controlled trial in China.

Authors:  Ruoyang Shao; Zhiwei Li; Jitao Wang; Ruizhao Qi; Qingbo Liu; Weijie Zhang; Xiaorong Mao; Xiaojing Song; Lei Li; Yanna Liu; Xin Zhao; Chuan Liu; Xun Li; Changzeng Zuo; Weidong Wang; Xiaolong Qi
Journal:  BMJ Open       Date:  2020-06-23       Impact factor: 2.692

3.  Transjugular Portosystemic Stent Shunt: Impact of Right Atrial Pressure on Portal Venous Hemodynamics Within the First Week.

Authors:  Michael Bernhard Pitton; Arndt Weinmann; Roman Kloeckner; Jens Mittler; Christian Ruckes; Christoph Düber; Gerd Otto
Journal:  Cardiovasc Intervent Radiol       Date:  2021-12-01       Impact factor: 2.740

4.  Serum Expression Level of MicroRNA-122 and Its Significance in Patients with Hepatitis B Virus Infection.

Authors:  Qingqing Fang; Wei Chen; Yourong Jian; Yu Li; Wei Lian; Hongyu Wan; Shiyao Chen; Feng Li; Ying Chen
Journal:  J Healthc Eng       Date:  2022-02-24       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.